Affiliation:
1. Mental Health Research Centre
Abstract
The aim was to study immediate and long-term (post-therapeutic) effects of a three-month course of therapy with citicoline in 1st-degree relatives of patients with Alzheimer’s disease (AD). All the included relatives of patients with AD revealed signs of minimal cognitive dysfunction (MCD) and mild cognitive decline syndrome (MCI — Mild Cognitive Impairment, ICD-10 code F06.7). Study participants: the study involved 90 first-degree relatives: 24 with MCI and 66 with MCD. Study design: an open-label comparative multidisciplinary study of the six-month dynamics of cognitive functioning of two groups of relatives who received a three-month course of citicoline therapy. The baseline indicators of the cognitive functioning of relatives with MCI syndrome and MKD were compared with the indicators at the end of the three-month course of therapy with citicoline at a daily dose of 1000 mg as well as 3 months after the end of the course of treatment. Methods: clinical, psychopathological, neuropsychological, psychometric, genetic, statistical ones. Results: а significant positive effect of the course therapy with citicoline on the cognitive impairment of 1st degree AD-patients’ relatives with minimal cognitive dysfunction and more pronounced cognitive impairments met the diagnostic criteria for MCI syndrome has been found. A significantly greater value of both immediate and long-term therapeutic effect of MKD compared with MCI in relatives was established by psychometric and neuropsychological indicators characterizing voluntary memorization of verbal and visual stimuli, optical and spatial activity, voluntary attention, and associative verbal thinking. Conclusion: the results of the study can be used as the basis for a model of prevention of the progression of cognitive deficit and the development of dementia in persons with a high risk of developing AD, i.e. in individuals with both genetic risk and signs of cognitive impairment.
Publisher
Medical Informational Agency Publishers
Reference22 articles.
1. La Rue A, O’Hara R, Matsuyama SS, Jarvik LF. Cognitive changes in young-old adults: effect of family history of dementia. J Clin Exp Neuropsychol. 1995;17:60–70. https://doi.org/10.1080/13803399508406582
2. Small GW, Okonek A, Mandelkern MA, La Rue A, Chang L, Khonsary A, Ropchan J., Blahd WH. Age-associated memory loss: initial neuropsychological and cerebral metabolic findings of a longitudinal study. Int Psychogeriatr. 1994;6:23–44. https://doi.org/10.1017/S1041610294001596
3. Jarvik LF, Brazer D. Children of Alzheimer parents: An Overview. J Geriatr Psychiatry Neurol. 2005;18:181– 186. https://doi.org/10.1177/0891988705281859
4. Selezneva ND, Roshchina IF, Gavrilova SI, Fedorova YaB, Gantman MV, Korovaitseva GI, Kunizheva SS, Rogaev EI. Psikhicheskie narusheniya kognitivnogo i nekognitivnogo spektra u rodstvennikov 1-i stepeni rodstva patsientov s bolezn'yu Al'tsgeimera. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112(10):8–13. Selezneva ND, Roshchina IF, Gavrilova SI, Fedorova YaB, Gantman M, Korovaytseva GI, Kunizheva SS, Rogayev EI. Mental disturbances of a cognitive and not cognitive range at relatives of 1 degree of relationship of patients with Alzheimer’s disease. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2012;112(10):8–13. (In Russ.).
5. Caselli RJ, Reiman EM, Osborne D, Hentz JG, Baxter LC, Hernandez JL Alexander GG. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology. 2004;62:1990–1995. https://doi.org/10.1212/01.wnl.0000129533.26544.bf
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献